As of 2025-06-17, the Relative Valuation of Intra-Cellular Therapies Inc (ITCI) is (13.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 131.87 USD, the upside of Intra-Cellular Therapies Inc based on Relative Valuation is -110.0%.
The range of the Relative Valuation is (13.00) - (12.80) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 18.3x | 18.1x |
| Forward P/E multiples | 18.5x - 20.1x | 19.5x |
| Fair Price | (13.00) - (12.80) | (13.18) |
| Upside | -109.9% - -109.7% | -110.0% |
| Date | P/E |
| 2025-04-01 | -188.10 |
| 2025-03-31 | -188.17 |
| 2025-03-28 | -188.02 |
| 2025-03-27 | -187.93 |
| 2025-03-26 | -187.85 |
| 2025-03-25 | -187.86 |
| 2025-03-24 | -187.86 |
| 2025-03-21 | -187.79 |
| 2025-03-20 | -187.72 |
| 2025-03-19 | -187.62 |
| 2025-03-18 | -187.50 |
| 2025-03-17 | -187.50 |